Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

D. van der Heijde; M.H. Schiff; J. Sieper; A.J. Kivitz; R.L. Wong; H. Kupper; B.A.C. Dijkmans; P.J. Mease; J.C. Davis

doi:10.1136/ard.2007.087270

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

D. van der Heijde, M.H. Schiff, J. Sieper, A.J. Kivitz, R.L. Wong, H. Kupper, B.A.C. Dijkmans, P.J. Mease, J.C. Davis

Rheumatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	922-929
Journal	Annals of the Rheumatic Diseases
Volume	68
Issue number	6
DOIs	https://doi.org/10.1136/ard.2007.087270
Publication status	Published - 2009

Access to Document

10.1136/ard.2007.087270

Cite this

van der Heijde, D., Schiff, M. H., Sieper, J., Kivitz, A. J., Wong, R. L., Kupper, H., Dijkmans, B. A. C., Mease, P. J., & Davis, J. C. (2009). Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial. Annals of the Rheumatic Diseases, 68(6), 922-929. https://doi.org/10.1136/ard.2007.087270

@article{b9ca777be1574eac9e5c418cdd67d58f,

title = "Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial",

author = "{van der Heijde}, D. and M.H. Schiff and J. Sieper and A.J. Kivitz and R.L. Wong and H. Kupper and B.A.C. Dijkmans and P.J. Mease and J.C. Davis",

year = "2009",

doi = "10.1136/ard.2007.087270",

language = "Undefined/Unknown",

volume = "68",

pages = "922--929",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "6",

}

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial. / van der Heijde, D.; Schiff, M.H.; Sieper, J.; Kivitz, A.J.; Wong, R.L.; Kupper, H.; Dijkmans, B.A.C.; Mease, P.J.; Davis, J.C.

In: Annals of the Rheumatic Diseases, Vol. 68, No. 6, 2009, p. 922-929.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

AU - van der Heijde, D.

AU - Schiff, M.H.

AU - Sieper, J.

AU - Kivitz, A.J.

AU - Wong, R.L.

AU - Kupper, H.

AU - Dijkmans, B.A.C.

AU - Mease, P.J.

AU - Davis, J.C.

PY - 2009

Y1 - 2009

U2 - 10.1136/ard.2007.087270

DO - 10.1136/ard.2007.087270

M3 - Article

C2 - 18701556

VL - 68

SP - 922

EP - 929

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 6

ER -